Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Investigate the Efficacy and Tolerability of AZD1446 in Adult ADHD Patients.

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT01012375
First received: November 11, 2009
Last updated: August 31, 2011
Last verified: September 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2010
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)